Improved hepatic toxicity profile of portal vein adjuvant hepatic infusional chemotherapy

Journal of Clinical Oncology

Volumn 23, Issue 22, 2005, Pages 4876-4880

  Faynsod, Moshe ^a   Wagman, Lawrence D ^a   Longmate, Jeff ^a   Carroll, Mary ^a   Leong, Lucille A ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLOXURIDINE; FLUOROURACIL; FOLINIC ACID; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIMETABOLITE;

ABDOMINAL PAIN; ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG DOSE ESCALATION; DRUG DOSE REDUCTION; DRUG INFUSION; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMAN; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; PANCREATITIS; PHASE 2 CLINICAL TRIAL; PORTAL VEIN; PRIORITY JOURNAL; TREATMENT REFUSAL; VEIN THROMBOSIS; DISEASE FREE SURVIVAL; INTRAVENOUS DRUG ADMINISTRATION; LIVER TUMOR; METASTASIS; MIDDLE AGED;

ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; FEMALE; FLOXURIDINE; FLUOROURACIL; HUMANS; INFUSIONS, INTRAVENOUS; LEUCOVORIN; LIVER NEOPLASMS; MALE; MIDDLE AGED; PORTAL VEIN;

EID: 24644492441     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.01.515     Document Type: Article

References (21)

1. Fong Y, Kemeny N, Paty P. et al. Treatment of colorectal cancer: Hepatic metastases. Semin Surg Oncol 12:219-252, 1996
2. Fortner JG: Recurrence of colorectal cancer after hepatic resection. Am J Surg 155:378-382, 1988
3. Breedis C, Young G: The blood supply of neoplasms in the liver. Am J Pathol 30:969-977, 1954
4. Ensminger WD, Gyves JW: Clinical pharmacology of hepatic arterial chemotherapy. Semin Oncol 10:176-182, 1983
5. Sigurdson ER, Ridge JA, Kemeny N, et al: Tumor and liver drug uptake following hepatic artery and portal vein infusion. J Clin Oncol 5:1836-1840, 1987
6. Hohn DC, Stagg RJ, Friedman MA, et al: A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: The Northern California Oncology Group trial. J Clin Oncol 7:1646-1654, 1989
7. Chang AE, Schneider PD, Sugarbaker PH, et al: A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg 206:685-693, 1987
8. Kemeny N, Daly J, Reichman B, et al: Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma: A randomized trial. Ann Intern Med 107:459-465, 1987
9. Kemeny N, Huang Y, Cohen AM, et al: Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med 341:2039-2048, 1999
10. Kemeny MM, Adak S, Gray B, et al: Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: Surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy-An intergroup study. J Clin Oncol 20:1499-1505, 2002
11. Hohn D, Melnick J, Stagg R, et al: Biliary sclerosis in patients receiving hepatic arterial infusions of floxuridine. J Clin Oncol 3:98-102, 1985
12. Haq MM, Valdes LG, Peterson DF, et al: Fibrosis of extrahepatic biliary system after continuous hepatic artery infusion of floxuridine through an implantable pump (Infusaid pump). Cancer 57:1281-1283, 1986
13. Ludwig J, Kim CH, Wiesner RH, et al: Floxuridine-induced sclerosing cholangitis: An ischemic cholangiopathy? Hepatology 9:215-218, 1989
14. Leong LA: Hepatic resection of colorectal cancer followed by portal vein infusion of fluorodeoxyuridine and systemic 5-fluorouracil and folinic acid. Proc Am Soc Clin Oncol 9:107, 1990 (abstr 414)
15. Wagman LD, Kemeny MM, Leong L, et al: A prospective, randomized evaluation of the treatment of colorectal cancer metastatic to the liver. J Clin Oncol 8:1885-1893, 1990
16. Kemeny MM, Battifora H, Blayney DW, et al: Sclerosing cholangitis after continuous hepatic artery infusion of FUDR. Ann Surg 202:176-181, 1985
17. Hohn D, Melnick J, Stagg R, et al: Biliary sclerosis in patients receiving hepatic arterial infusions of floxuridine. J Clin Oncol 3:98-102, 1985
18. Davidson BS, Izzo F, Chase JL, et al: Alternating floxuridine and 5-fluorouracil hepatic arterial chemotherapy for colorectal liver metastases minimizes biliary toxicity. Am J Surg 172: 244-247, 1996
19. Andrews JC, Kuntsen C, Terio P, et al: Hepatobiliary toxicity of 5-fluoro-2′-deoxyuridine: Intra-arterial versus portal venous routes of infusion. Invest Radiol 26:461-464, 1991
20. Daly JM, Kemeny N, Sigurdson E, et al: Regional infusion for colorectal hepatic metastases: A randomized trial comparing the hepatic artery with the portal vein. Arch Surg 122:1273-1277, 1987
21. Kemeny N, Jarnagin W, Gonen M, et al: Phase I/II study of hepatic arterial therapy with floxuridine and dexamethasone in combination with intravenous irinotecan as adjuvant treatment after resection of hepatic metastases from colorectal cancer. J Clin Oncol 21:3303-3309, 2003